Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 48: 1412-1417, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stamer, U. M.
Right arrow Articles by Stüber, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stamer, U. M.
Right arrow Articles by Stüber, F.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Drug Monitoring and Toxicology
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2002;48:1412-1417.)
© 2002 American Association for Clinical Chemistry, Inc.

Rapid and Reliable Method for Cytochrome P450 2D6 Genotyping

Ulrike M. Stamera1, Bettina Bayerer1, Stephanie Wolf1, Andreas Hoeft1 and Frank Stüber1

1 Department of Anesthesiology and Intensive Care Medicine, University of Bonn, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany.

aAuthor for correspondence. Fax 49-228-2876754; e-mail ulrike.stamer{at}ukb.uni-bonn.de.

Background: Single-nucleotide polymorphisms and single-base deletions within the cytochrome P450 2D6 (CYP2D6) gene have been associated with a poor metabolizer (PM) phenotype and display a frequency of 7–10% in the Caucasian population.

Methods: We developed a reliable and rapid procedure to identify five major PM-associated mutations (CYP2D6*4, *7, and *8) and deletions (CYP2D6*3 and *6) by real-time PCR with subsequent fluorometric melting point analysis of the PCR product. These polymorphisms within the CYP2D6 gene were detected by use of two primer pairs and five different pairs of hybridization probes. DNA extracted from whole blood of 323 individuals was analyzed, and results were compared with genotypes obtained by allele-specific multiplex PCR. In case of uncertain results, additional sequence analysis was performed.

Results: Genotyping results by real-time PCR were 100% reliable, whereas conventional allele-specific multiplex PCR produced uncertain results for 12.1% of samples, as confirmed by sequence analysis. Costs for reagents and consumables were considerably higher for the real-time PCR technology, but labor time was reduced by 2 h compared with allele-specific PCR. The allele frequencies in the population investigated were 0.186 for allele *4, 0.026 for allele *5, 0.009 for allele *3, 0.031 for allele *6, and 0.002 for allele *8. The defective CYP2D6*7 allele was not found. In addition, three additional mutations were detected, one of them displaying a PM genotype.

Conclusion: Genotyping of CYP2D6 by real-time PCR with fluorometric melting point analysis is a rapid and reliable method.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
J. Sistonen, S. Fuselli, A. Levo, and A. Sajantila
CYP2D6 Genotyping by a Multiplex Primer Extension Reaction
Clin. Chem., July 1, 2005; 51(7): 1291 - 1295.
[Full Text] [PDF]


Home page
Clin Med ResHome page
Y. Jiang, T. Ellis, and A. R. Greenlee
Genotyping Parkinson Disease-Associated Mitochondrial Polymorphisms
Clin. Med. Res., May 1, 2004; 2(2): 99 - 106.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
B. Muller, K. Zopf, J. Bachofer, and W. Steimer
Optimized Strategy for Rapid Cytochrome P450 2D6 Genotyping by Real-Time Long PCR
Clin. Chem., October 1, 2003; 49(10): 1624 - 1631.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.